Changes in CV Biomarkers in Patients Switching ART RegimensChanges in CV Biomarkers in Patients Switching ART Regimens

Switching from ritonavir-boosted protease inhibitors to raltegravir leads to significant changes in plasma lipids and CV biomarkers. What does this mean for HIV patients' CV health? AIDS
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news